%0 Journal Article
%T Three-dimensional cell culture: Future scope in cancer vaccine development.
%A Rahman M
%A Sahoo A
%A Almalki WH
%A Salman Almujri S
%A Aodah A
%A Alnofei AA
%A Alhamyani A
%J Drug Discov Today
%V 29
%N 9
%D 2024 Sep 25
%M 39067612
%F 8.369
%R 10.1016/j.drudis.2024.104114
%X Three-dimensional (3D) cell culture techniques, which are superior to 2D methods in viability and functionality, are being used to develop innovative cancer vaccines. Tumor spheroids, which are structurally and functionally similar to actual tumors, can be developed using 3D cell culture. These spheroid vaccines have shown superior antitumor immune responses to 2D cell-based vaccines. Dendritic cell vaccines can also be produced more efficiently using 3D cell culture. Personalized cancer vaccines are being developed using 3D cell culture, providing substantial benefits over 2D methods. The more natural conditions of 3D cell culture might promote the expression of tumor antigens not expressed in 2D culture, potentially allowing for more targeted vaccines by co-culturing tumor cells with other cell types. Advanced cancer vaccines using 3D cell cultures are expected soon.